Publication & Citation Trends
Publications
0 total
Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
Cited by 0
Semantic Scholar
Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroups
Cited by 1
Semantic Scholar
MM-286 Single Cell Multi-Omic Clonal Tracking in Myeloma Identifies SMM Clones That Progress to MM and Low Frequency MM Clones With Resistance Features Enabling More Precise Application of Targeted Therapies
Cited by 0
Semantic Scholar
Single-Cell Multi-omic Clonal Tracking in Myeloma Identifies Smm Clones That Progress to MM and Low-Frequency MM Clones With Resistance Features Enabling More Precise Application of Targeted Therapies
Cited by 0
Semantic Scholar
BRAVE: A Phase 2 Trial Evaluating the Efficacy and Safety of Venetoclax in Combination with Bruton's Tyrosine Kinase Inhibitors in Patients with First-Line Chronic Lymphocytic Leukemia
Cited by 1
Semantic Scholar
Using Single Cell Multi-Omic Clonal Tracking in SMM to Identify Clones That Progress to MM and Harbor Treatment Resistance Features
Cited by 0
Semantic Scholar
Abstract B010: Systematical evaluation on alternative splicing in immune-related therapy targets reveals innate and acquired therapy resistance mechanisms in multiple myeloma
Cited by 1
Semantic Scholar
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma OA
Cited by 9
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(66)
Protein Degradation and Inhibitors
(37)
Immunotherapy and Immune Responses
(19)
RNA Interference and Gene Delivery
(13)
Monoclonal and Polyclonal Antibodies Research
(11)
Affiliations
University of Delhi
Amgen (United States)
Presidency University
Centre for Cellular and Molecular Biology
University of California System